COMMUNIQUÉS West-GlobeNewswire

Zenith Announces Voting Results from the 2018 Annual Meeting of Shareholders
13/09/2018
Archive of the Executive Presentation to be Posted to the Zenith Website CALGARY, Alberta, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual meeting of [...]
Novartis announces NEJM publication of landmark PARADIGMS study demonstrating significant benefit of Gilenya® in children and adolescents with MS
12/09/2018
Treatment with Gilenya (fingolimod) substantially reduced the debilitating impact of MS, with significant decreases in key measures of disease activity vs. interferon beta-1a MS severely affects the everyday lives of [...]
Galapagos announces launch of proposed public offering
12/09/2018
Mechelen, Belgium, 12 September 2018, 22.45 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that it intends to offer and sell, subject to market and other conditions, $300 million [...]
Foamix Announces Proposed Follow-on Offering of Ordinary Shares
12/09/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]
Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
12/09/2018
ALPHARETTA, Ga., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Adamas Announces New Employment Inducement Grant
12/09/2018
EMERYVILLE, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted six new employees the option [...]
Verrica Announces Successful Phase 2 Innovate Trial and Complete Enrollment of Phase 3 Trials of VP-102 in Molluscum Contagiosum Ahead of Schedule
12/09/2018
Innovate trial results reaffirm Phase 3 protocol design No serious adverse events (SAEs) reported during the Innovate trial Phase 3 pivotal trials for molluscum contagiosum fully enrolled and topline results now [...]
MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
12/09/2018
Mechelen, Belgium and Planegg/Munich, Germany; 12 September 2018; 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) announced today the [...]
Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
12/09/2018
BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced that it has commenced an [...]
Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404
12/09/2018
-Meets Co-Primary Endpoint of Specificity; 1404 Successfully Identifies Patients Without Clinically Significant Prostate Cancer- -Co-Primary Endpoint of Sensitivity to Identify Patients with Clinically Significant [...]
Présentation corporative de Pediapharm
12/09/2018
NE PAS DISTRIBUER AUX SERVICES DE TRANSMISSION DE NOUVELLES DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNIS. LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION EN VALEURS MOBILIÈRES DES ÉTATS- [...]
Pediapharm Files Corporate Presentation
12/09/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 12, [...]
Intermountain Healthcare Now Delivers the Nation’s First “One Stick” Hospitalization for Inpatient Blood Draws
12/09/2018
Intermountain, investing in human-centered quality improvements, sets the new clinical standard for safer, more efficient, and more humane blood collection Salt Lake City, UTAH, Sept. 12, 2018 (GLOBE NEWSWIRE) -- As [...]
THE NINTH EDITION OF THE INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH ARRIGO RECORDATI HAS ANNOUNCED THE CALL FOR NOMINATIONS
12/09/2018
The 2019 € 100.000 Award will be dedicated to the promotion and recognition of excellence in orphan disease treatment research . Milan, September 2018 The International Prize for Scientific Research Arrigo Recordati has [...]
PSIQ Announces “No Toxic Debt and No Reverse Stock Split”
12/09/2018
SUNRISE, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the company is without toxic debt and there will be no reverse stock split of PSIQ common stock in the [...]
FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
12/09/2018
SAN FRANCISCO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the [...]
REDUCE-IT™ Trial Primary Results Accepted for Presentation at 2018 Scientific Sessions of American Heart Association
12/09/2018
Topline Results of the REDUCE-IT Study Anticipated Before End of September 2018 BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company [...]
FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
12/09/2018
Trial to be Led by Experts from University of California Los Angeles (UCLA) and University of Virginia (UVA) To Expand Treatment Window, Improve Patient Outcomes for Stroke CHARLOTTESVILLE, Va., Sept. 12, 2018 (GLOBE [...]
Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award
12/09/2018
CAMBRIDGE, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST) today congratulated Dr. C. David Allis and Dr. Michael Grunstein, the co-recipients of the 2018 Albert Lasker [...]

Pages